Showing results (1271-1280 of 1,724) with videos related to
Sort By:
Pageof 173
CNS Spectrums|January 4, 2019
Increased risk of type 2 diabetes among the siblings of patients with schizophreniaMao-Hsuan Huang, Mu-Hong Chen, Kai-Lin Huang, et al.CNS Spectrums|November 1, 2006
Calming the bipolar storm: treating acute mania and mixed episodes in patients with bipolar disorderJohn M ZajeckaCNS Spectrums|March 3, 2007
Modulation of fear and anxiety by the endogenous cannabinoid systemJasmeer P Chhatwal, Kerry J ResslerCNS Spectrums|September 2, 2006
Borderline personality disorder and traits in veterans: psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severityDonald W Black, Nancee Blum, Elena Letuchy, et al.CNS Spectrums|September 2, 2006
Healthcare resource utilization in bipolar depression compared with unipolar depression: results of a United States population-based studyMark A Frye, Joseph R Calabrese, Michael L Reed, et al.CNS Spectrums|September 5, 2006
The timing of neurodevelopmental abnormality in schizophrenia: an integrative review of the neuroimaging literatureT Lencz, R M Bilder, B CornblattCNS Spectrums|December 29, 2006
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hourLawrence F Blob, Melvin Sharoky, Bryan J Campbell, et al.CNS Spectrums|December 29, 2006
The switching of risperidone to olanzapine in elderly nursing-home patients with dementia: a retrospective studySubramoniam Madhusoodanan, Olivera BogunovicCNS Spectrums|December 29, 2006
Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disordersMichael W Otto, Shawnee L Basden, Teresa M Leyro, et al.CNS Spectrums|December 29, 2006
Coenzyme Q10: a review of its promise as a neuroprotectantA Joyce Young, Stephanie Johnson, David C Steffens, et al.Pageof 173